Literature DB >> 12928038

Disease model: Parkinson's disease.

Shun Shimohama1, Hideyuki Sawada, Yoshihisa Kitamura, Takashi Taniguchi.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder that is primarily characterized by the degeneration of dopaminergic neurons in the nigrostriatal pathway. The pathology of PD is typified by the presence of cytoplasmic inclusions (Lewy bodies) containing alpha-synuclein and ubiquitin. The pathogenesis of PD is not completely understood but environmental and genetic factors are thought to play important roles. To understand the pathophysiology of PD, and to develop novel therapies for improved symptomatic management, it is important to have relevant disease models. In this review, we summarize the available in vivo and in vitro models of PD and discuss their value.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928038     DOI: 10.1016/s1471-4914(03)00117-5

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  44 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease.

Authors:  Alicia M Pickrell; Milena Pinto; Aline Hida; Carlos T Moraes
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

3.  CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist.

Authors:  Jianyong Chen; Gregory T Collins; Beth Levant; James Woods; Jeffrey R Deschamps; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2011-08-11       Impact factor: 4.345

4.  Neuroprotective Effects of Germinated Brown Rice in Rotenone-Induced Parkinson's-Like Disease Rats.

Authors:  Supin Chompoopong; Sunit Jarungjitaree; Tideeporn Punbanlaem; Thanaporn Rungruang; Sukumal Chongthammakun; Aikkarach Kettawan; Thongchai Taechowisan
Journal:  Neuromolecular Med       Date:  2016-07-18       Impact factor: 3.843

5.  Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

Authors:  Marine Hovakimyan; Stefan Jean-Pierre Haas; Oliver Schmitt; Bernd Gerber; Andreas Wree; Christian Andressen
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

6.  Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.

Authors:  Mahboubeh Manouchehrabadi; Mona Farhadi; Zahra Azizi; Anahita Torkaman-Boutorabi
Journal:  Neurotox Res       Date:  2019-07-30       Impact factor: 3.911

7.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

8.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

9.  Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.

Authors:  Jun Kawamata; Syuuichirou Suzuki; Shun Shimohama
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

10.  Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.

Authors:  Wei Zhang; Kester Phillips; Albert R Wielgus; Jie Liu; Alberto Albertini; Fabio A Zucca; Rudolph Faust; Steven Y Qian; David S Miller; Colin F Chignell; Belinda Wilson; Vernice Jackson-Lewis; Serge Przedborski; Danielle Joset; John Loike; Jau-Shyong Hong; David Sulzer; Luigi Zecca
Journal:  Neurotox Res       Date:  2009-12-03       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.